Literature DB >> 28520580

High Agreement Between Benchtop and Point-of-Care Dipcard Tests for Ethyl Glucuronide.

Emily Leickly1, Jordan Skalisky, Sterling McPherson, Michael F Orr, Michael G McDonell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28520580      PMCID： PMC5513150          DOI： 10.1097/FTD.0000000000000412

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN： 0163-4356            Impact factor:   3.681


× No keyword cloud information.
  12 in total

1.  Voucher-based reinforcement for alcohol abstinence using the ethyl-glucuronide alcohol biomarker.

Authors:  Michael G McDonell; Donelle N Howell; Sterling McPherson; Jennifer M Cameron; Debra Srebnik; John M Roll; Richard K Ries
Journal:  J Appl Behav Anal       Date:  2012

2.  Clinical (nonforensic) application of ethyl glucuronide measurement: are we ready?

Authors:  Peter Jatlow; Stephanie S O'Malley
Journal:  Alcohol Clin Exp Res       Date:  2010-04-05       Impact factor: 3.455

3.  An evaluation of the DRI-ETG EIA method for the determination of ethyl glucuronide concentrations in clinical and post-mortem urine.

Authors:  Sophie C Turfus; Tu Vo; Nadia Niehaus; Dimitri Gerostamoulos; Jochen Beyer
Journal:  Drug Test Anal       Date:  2012-02-28       Impact factor: 3.345

4.  Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients.

Authors:  Michael G McDonell; Jordan Skalisky; Emily Leickly; Sterling McPherson; Samuel Battalio; Jenny R Nepom; Debra Srebnik; John Roll; Richard K Ries
Journal:  Drug Alcohol Depend       Date:  2015-10-09       Impact factor: 4.492

5.  Improved detection of ethyl glucuronide and ethyl sulfate in a pain management population using high-throughput LC-MS/MS.

Authors:  Bridgit Crews; Sergey Latyshev; Charles Mikel; Perla Almazan; Robert West; Amadeo Pesce; Cameron West
Journal:  J Opioid Manag       Date:  2010 Nov-Dec

6.  Determining ethyl glucuronide cutoffs when detecting self-reported alcohol use in addiction treatment patients.

Authors:  Jessica M Lowe; Michael G McDonell; Emily Leickly; Frank A Angelo; Roger Vilardaga; Sterling McPherson; Debra Srebnik; John Roll; Richard K Ries
Journal:  Alcohol Clin Exp Res       Date:  2015-04-10       Impact factor: 3.455

7.  High levels of agreement between clinic-based ethyl glucuronide (EtG) immunoassays and laboratory-based mass spectrometry.

Authors:  Emily Leickly; Michael G McDonell; Roger Vilardaga; Frank A Angelo; Jessica M Lowe; Sterling McPherson; Debra Srebnik; John M Roll; Richard K Ries
Journal:  Am J Drug Alcohol Abuse       Date:  2015-02-19       Impact factor: 3.829

8.  Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials.

Authors:  Peter I Jatlow; Ann Agro; Ran Wu; Haleh Nadim; Benjamin A Toll; Elizabeth Ralevski; Christine Nogueira; Julia Shi; James D Dziura; Ismene L Petrakis; Stephanie S O'Malley
Journal:  Alcohol Clin Exp Res       Date:  2014-04-28       Impact factor: 3.455

9.  Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alcohol detoxification.

Authors:  Anders Helander; Michael Böttcher; Christoph Fehr; Norbert Dahmen; Olof Beck
Journal:  Alcohol Alcohol       Date:  2008-10-29       Impact factor: 2.826

10.  Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness.

Authors:  Michael G McDonell; Debra Srebnik; Frank Angelo; Sterling McPherson; Jessica M Lowe; Andrea Sugar; Robert A Short; John M Roll; Richard K Ries
Journal:  Am J Psychiatry       Date:  2013-01       Impact factor: 18.112
View more
  4 in total

1.  Higher Levels of Alcohol Use Are Associated With Latent Tuberculosis Infection in Adults Living With Human Immunodeficiency Virus.

Authors:  Sarah B Puryear; Robin Fatch; Brian Beesiga; Allen Kekibiina; Sara Lodi; Kara Marson; Nneka I Emenyonu; Winnie R Muyindike; Dalsone Kwarisiima; Judith A Hahn; Gabriel Chamie
Journal:  Clin Infect Dis       Date:  2021-03-01       Impact factor: 9.079

2.  The Drinkers' Intervention to Prevent Tuberculosis (DIPT) trial among heavy drinkers living with HIV in Uganda: study protocol of a 2×2 factorial trial.

Authors:  Sara Lodi; Nneka I Emenyonu; Kara Marson; Dalsone Kwarisiima; Robin Fatch; Michael G McDonell; Debbie M Cheng; Harsha Thirumurthy; Monica Gandhi; Carol S Camlin; Winnie R Muyindike; Judith A Hahn; Gabriel Chamie
Journal:  Trials       Date:  2021-05-20       Impact factor: 2.279

3.  Concordance Between Point-of-Care Urine Ethyl Glucuronide Alcohol Tests and Self-Reported Alcohol Use in Persons with HIV in Uganda.

Authors:  Karl C Alcover; Nneka I Emenyonu; Robin Fatch; Allen Kekibiina; Kara Marson; Gabriel Chamie; Winnie R Muyindike; Brian Beesiga; Moses R Kamya; Sara Lodi; Jeremy C Kane; Judith A Hahn; Michael G McDonell
Journal:  AIDS Behav       Date:  2022-02-01

4.  Computer-based alcohol reduction intervention for alcohol-using HIV/HCV co-infected Russian women in clinical care: study protocol for a randomized controlled trial.

Authors:  Ralph J DiClemente; Jennifer L Brown; Ariadna Capasso; Natalia Revzina; Jessica M Sales; Ekaterina Boeva; Lyudmila V Gutova; Nadia B Khalezova; Nikolay Belyakov; Vadim Rassokhin
Journal:  Trials       Date:  2021-02-17       Impact factor: 2.279
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.